ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Pulmonary Disease

Top Pulmonary Disease Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOSE PEREZ M.D.

Pulmonary Disease

23,700

$2.7M

928
588 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

37%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 56%

$114
Average prescription price

Avg: $166

JUNJI HIGUCHI MD

Pulmonary Disease

20,018

$1.56M

572
412 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

26%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 56%

$78
Average prescription price

Avg: $166

MUHAMMAD HANIF M.D.

Pulmonary Disease

19,208

$919K

1105
894 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

21%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 56%

$48
Average prescription price

Avg: $166

RICHARD POHIL M.D.

Pulmonary Disease

14,027

$831K

873
807 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 56%

$59
Average prescription price

Avg: $166

MIGUEL FRANCO M.D.

Pulmonary Disease

13,081

$691K

618
574 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 56%

$53
Average prescription price

Avg: $166

WINDER VASQUEZ MD

Pulmonary Disease

12,112

$856K

447
379 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 56%

$71
Average prescription price

Avg: $166

BENJAMIN INTERIANO M.D.

Pulmonary Disease

11,814

$688K

582
507 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 56%

$58
Average prescription price

Avg: $166

PANKAJ PATEL M.D.

Pulmonary Disease

11,785

$973K

913
753 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 56%

$83
Average prescription price

Avg: $166

LOUIS MENDOZA MD

Pulmonary Disease

11,133

$554K

537
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 56%

$50
Average prescription price

Avg: $166

BRUCE ACKERMAN D.O.

Pulmonary Disease

10,332

$556K

301
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

37%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 56%

$54
Average prescription price

Avg: $166

CARLOS PEREZ MD

Pulmonary Disease

10,013

$643K

545
390 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

26%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 56%

$64
Average prescription price

Avg: $166

THOMAS BAKER M.D.

Pulmonary Disease

9,617

$1.15M

683
606 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 56%

$119
Average prescription price

Avg: $166

NOBLE EZUKANMA M.D.

Pulmonary Disease

8,309

$744K

1105
523 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

35%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 56%

$90
Average prescription price

Avg: $166

LAURENCE CUNNINGHAM D.O.

Pulmonary Disease

7,947

$488K

340
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

19%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 56%

$61
Average prescription price

Avg: $166

TERRY KILGORE M.D.

Pulmonary Disease

7,695

$426K

289
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 56%

$55
Average prescription price

Avg: $166

BENSON HUANG M.D.

Pulmonary Disease

7,249

$620K

601
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 56%

$86
Average prescription price

Avg: $166

CARLOS LLANES MD

Pulmonary Disease

6,131

$381K

225
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 56%

$62
Average prescription price

Avg: $166

JESUS SAHAD M.D.

Pulmonary Disease

5,749

$932K

388
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 56%

$162
Average prescription price

Avg: $166

JOHN UPDEGROVE MD

Pulmonary Disease

5,544

$340K

341
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 56%

$61
Average prescription price

Avg: $166

VARSHA TASKAR MD

Pulmonary Disease

5,099

$916K

401
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 56%

$180
Average prescription price

Avg: $166

BHADRESH SHAH M.D.

Pulmonary Disease

4,713

$644K

431
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 56%

$137
Average prescription price

Avg: $166

CHRISTIAN MALUF MD

Pulmonary Disease

4,669

$788K

657
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

80%
prescriptions for brand name drugs

Avg: 56%

$169
Average prescription price

Avg: $166

MUKESH SARAIYA MD

Pulmonary Disease

4,657

$452K

364
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 56%

$97
Average prescription price

Avg: $166

ROBERT ZIMMERMAN M.D.

Pulmonary Disease

4,411

$346K

430
315 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 56%

$78
Average prescription price

Avg: $166

ALEX LECHIN M.D., F.C.C.P.

Pulmonary Disease

4,345

$998K

410
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 56%

$230
Average prescription price

Avg: $166

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank